NR514-NEED RESPONSES Importance of educational efforts and harm reduction practices regarding opioid use disorders. Thank you for w
I need help responding to the attached 4 peers' post in 150 words each. You will need to watch and listen to the students’ video using the links attached or the word documents.
NR514-NEED RESPONSES
I need help responding to the attached 4 peers' post in 150 words each. You will need to watch and listen to the students’ video using the links attached or the word documents.
I hope you are all able to view my video and find it entertaining and informational. Please let me know if you have any trouble with viewing. I have attached two links for you to use. Thank you!
https://web.microsoftstream.com/video/e15a2b5a-ca32-48ce-9441-a02fc8db21f3
https://web.microsoftstream.com/video/24548df6-4806-43b8-9cfb-dba40c2b7ba3?list=studio
Hi, everyone. Here is my elevator pitch about the importance of educational efforts and harm reduction practices regarding opioid use disorders. Thank you for watching!
Watch 'Opiod Use Elevator Pitch' | Microsoft Stream
Promoting Interventions that Decrease Stigma Related to Opioid Use
Statistics reveal that over 60% of individuals with addiction have a co-occurring mental health concern (Jones & McCance-Katz, 2019) and those with mental health concerns are more likely to use drugs of abuse than those without mental health concerns (SAMHSA, 2020a; SAMHSA, 2020b). This project involved a case study training for health professionals analyzing the case of a former patient who was opioid dependent. The patient was over 65, had a chronic pain condition, hx of early childhood trauma and of domestic violence, a dx of depression and suicidal ideation. The case study allowed staff to explore the treatment course and outcomes. In the training, we reviewed the pathophysiology of addiction, different treatment approaches and the importance of person-first language. The case study training will help health professionals engage in thoughtful dialogue that will improve awareness and self-examine to determine personal biases.
According to the CDC, the United States had over 100,000 opioid overdoses in 2021 (CDC, 2021). The opioid epidemic has claimed many lives and is destroying too many families. Addiction is a treatable medical condition and not a moral failing. Efforts to decrease barriers is relevant to improve care and outcomes. People who use substances often face discrimination which can get in the way of treatment. Believe it or not, health care workers are not immune to personal biases toward individuals who use substances. Provider stigma is defined as negative attitudes, perceptions, and behaviors that professionals hold towards patients – and poses a critical barrier to effective delivery of care (National Institute of Drug Abuse [NIDA] n.d.).
In addition, the case study training will help establish the rationale for funding for future educational efforts of harm reduction efforts in communities and health care settings. Harm reduction practices include education relating to prevention, evidence-based treatment, and compassionate care. Through educating others, we can help them understand the science of addiction and the importance of harm-reduction and prevention strategies. Thank you for listening!
References
Centers for Disease Control. (2021, Nov. 17). Drug Overdose Deaths in the U.S. Top 100,000 Annually [Press release]. https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2021/20211117.htm
Jones, C. M., & McCance-Katz, E. F. (2019). Co-occurring substance use and mental disorders among adults with opioid use disorder. Drug and Alcohol Dependence, 197, 78-82. https://doi.org/10.1016/j.drugalcdep.2018.12.030
National Institute of Drug Abuse. (n.d.). Healthcare Provider Stigma Related to the Opioid Use Epidemic and its Impact on Patient Treatment and Clinical Management. https://nida.nih.gov/about-nida/organization/cctn/ctn/research-studies/healthcare-provider-stigma-related-to-opioid-use-epidemic-its-impact-patient-treatment-clinical
Substance Abuse and Mental Health Services Administration (SAMHSA). (2020a). Key substance use and mental health indicators in the United States: Results from the 2019 National Survey on Drug Use and Health (HHS Publication No. PEP20-07-01-001, NSDUH Series H-55). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. https://www.samhsa.gov/data/
Substance Abuse and Mental Health Services Administration (SAMHSA). (2020b). Substance use disorder treatment for people with co-occurring disorders. Treatment Improvement Protocol (TIP) Series, No. 42. SAMHSA Publication No. PEP20-02-01-004. Rockville, MD: Substance Abuse and Mental Health Services Administration. https://store.samhsa.gov/sites/default/files/SAMHSA_Digital_Download/PE…
https://web.microsoftstream.com/video/972d005f-2fae-4230-98a9-39af594171a5
References
Biancarelli, D. L., Biello, K. B., Childs, E., Drainoni, M., Salhaney, P., Edeza, A., Mimiaga, M. J., Saitz, R., & Bazzi, A. R. (2019). Strategies used by people who inject drugs to avoid stigma in healthcare settings. Drug and Alcohol Dependence, 198, 80-86. https://doi.org/10.1016/j.drugalcdep.2019.01.037
Centers for Disease Control and Prevention (CDC). (2020, November 19). Hepatitis C tables & figures from the 2017 surveillance report. https://www.cdc.gov/hepatitis/statistics/2017surveillance/TablesFigures-HepC.htm
Centers for Disease Control and Prevention (CDC). (2018, August 31). Infectious diseases, opioids, and injection drug use | persons who inject drugs. https://www.cdc.gov/pwid/opioid-use.html
Centers for Disease Control and Prevention (CDC). (2021, June 3). NP report 2025 goal: Reduce HCV rate among PWID. https://www.cdc.gov/hepatitis/policy/npr/2021/NationalProgressReport-HepC-ReduceInfectionsPWID.htm
Centers for Disease Control and Prevention (CDC). (2019, November 14) Viral hepatitis surveillance. United States, 2017. https://www. cdc.gov/hepatitis/statistics/2017surveillance/index.htm.
Doerrbecker, J., Behrendt, P., Mateu-Gelabert, P., Ciesek, S., Riebesehl, N., Wilhelm, C., Steinmann, J., Pietschmann, T., & Steinmann, E. (2013). Transmission of hepatitis C virus among people who inject drugs: Viral stability and association with drug preparation equipment. The Journal of Infectious Diseases, 207(2), 281-287. https://doi.org/10.1093/infdis/jis677
Donyavi, T., Bokharaei-Salim, F., Khanaliha, K., Sheikh, M., Bastani, M., Moradi, N., Babaei, R., Habib, Z., Fakhim, A., & Esghaei, M. (2019). High prevalence of occult hepatitis C virus infection in injection drug users with HIV infection. Archives of Virology, 164(10), 2493-2504. https://doi.org/10.1007/s00705-019-04353-3
Duryea, P., B.A., Habchi, J., PharmD., Sprecht-Walsh, S., Thomas, A., M.Sc, & Bratberg, J., PharmD. (2020). A modifiable barrier to hepatitis C virus elimination in Rhode Island: The prior authorization process for direct-acting antiviral agents. Rhode Island Medical Journal, 103(5), 41-44.
Erman, A., Wong, W. W. L., Feld, J. J., Grootendorst, P., & Krahn, M. D. (2020). The health impact of delaying direct‐acting antiviral treatment for chronic hepatitis C: A decision‐analytic approach. Liver International, 40(1), 51-59. https://doi.org/10.1111/liv.14247
Fernandes, R. M., Cary, M., Duarte, G., Jesus, G., Alarcão, J., Torre, C., Costa, S., Costa, J., & Carneiro, A. V. (2017). Effectiveness of needle and syringe programmes in people who inject drugs – an overview of systematic reviews. BMC Public Health, 17(1), 309-309. https://doi.org/10.1186/s12889-017-4210-2
Flanigan, C. A., Leung, S. J., Rowe, K. A., Levey, W. K., King, A., Sommer, J. N., Morne, J. E., & Zucker, H. A. (2017). Evaluation of the impact of mandating health care providers to offer hepatitis C virus screening to all persons born during 1945–1965 — New York, 2014. MMWR. Morbidity and Mortality Weekly Report, 66(38), 1023-1026. https://doi.org/10.15585/mmwr.mm6638a3
Please see below the link for my "Elevator Pitch". I've also included my script with references.
https://web.microsoftstream.com/video/956a83cd-e5f0-4909-9ebe-906f280ce99a
The title of my project is “Addressing disparities in women’s health” and aims to prevent unintended pregnancies by increasing use of highly-effective birth control by minority women. Research continues to show vast disparities in the use of highly-effective birth control among minority women, as well as higher rates of unintended pregnancies. Research shows that approximately 69% of pregnancies among Black women and 54% among Hispanics are unintended, compared with 40% among white women (Dehlendorf et al., 2014).. With the current uncertainty of Roe V. Wade and access to abortion services across the United States under siege, addressing unintended pregnancies by promoting preventative measures such as highly-effective birth control is imperative at this time. The main proposed intervention is increasing the use of highly effective birth control among minority women by 2%. This can be attained following the proposed interventions of providing education various birth control methods to nurses and providing education to patient care providers on disparities in use and biases. The evaluation plan includes identifying patients already on a highly-effective birth control and comparing that to after the nurses and patient care providers have been educated. Also included is measuring for an 80% completion rate of education among nurses and patient care providers.
References
Dehlendorf, C., MD MAS, Rodriguez, M. I., MD, Levy, K., BA, Borrero, S., MD MS, & Steinauer, J., MD MAS. (2014). Disparities in Family Planning. American Journal of Obstetrics and Gynecology, 202 (3), 214-220. https://doi:10.1016/j.ajog.2009.08.022
Collepals.com Plagiarism Free Papers
Are you looking for custom essay writing service or even dissertation writing services? Just request for our write my paper service, and we'll match you with the best essay writer in your subject! With an exceptional team of professional academic experts in a wide range of subjects, we can guarantee you an unrivaled quality of custom-written papers.
Get ZERO PLAGIARISM, HUMAN WRITTEN ESSAYS
Why Hire Collepals.com writers to do your paper?
Quality- We are experienced and have access to ample research materials.
We write plagiarism Free Content
Confidential- We never share or sell your personal information to third parties.
Support-Chat with us today! We are always waiting to answer all your questions.
